As the global leader in the hearing care retail industry, we have been changing the lives of millions of customers across the globe since 1950. With stores and offices spanning across 25 countries and a team of 18,600 dedicated professionals, we take pride in setting the industry standard as we empower people to rediscover all the emotions of sound.
Although we are constantly growing, we have the drive of a start-up and are committed to striving for innovation every day. Whatever role our employees take on at Amplifon, they each make more possible - more brands for customers, more support for colleagues, more opportunities for their own careers and more innovative possibilities. We are guided by our values and are motivated by our purpose, ensuring each new day brings opportunities for innovation as we explore new horizons for our business, our customers and each other. At Amplifon, we make more possible.
Worldwide
HeadquartersVia Ripamonti 131/133, 20141 Milano – Italy
Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|
Noncurrent Derivative Financial Assets | N/A | 10,983,000.00 | 25,850,000.00 |
Other Noncurrent Assets | N/A | 40,773,000.00 | 42,470,000.00 |
Current Trade Receivables | N/A | 168,680,000.00 | 192,067,000.00 |
Other Current Receivables | N/A | 91,555,000.00 | 72,610,000.00 |
Cash and cash equivalents | 545,027,000.00 | 268,546,000.00 | 179,654,000.00 |
Current Derivative Financial Assets | N/A | 168,000.00 | 17,016,000.00 |
Retained Earnings Profit Loss For Reporting Period | N/A | 157,785,000.00 | 178,525,000.00 |
Retained Earnings Excluding Profit Loss For Reporting Period | N/A | 594,266,000.00 | 691,409,000.00 |
Noncurrent Contract Liabilities | N/A | 144,414,000.00 | 153,613,000.00 |
Noncurrent Derivative Financial Liabilities | N/A | 2,531,000.00 | 0.00 |
Other Noncurrent Liabilities | N/A | 16,318,000.00 | 16,123,000.00 |
Trade And Other Current Payables To Trade Suppliers | N/A | 242,507,000.00 | 325,583,000.00 |
Current Contract Liabilities | N/A | 107,414,000.00 | 114,857,000.00 |
Current Derivative Financial Liabilities | N/A | 552,000.00 | 0.00 |
Other Current Liabilities | N/A | 211,475,000.00 | 167,796,000.00 |
Line item in (eur) | 01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|
Revenue From Contracts With Customers | 1,948,075,000.00 | 2,119,126,000.00 |
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 222,326,000.00 | 240,040,000.00 |
Profit (loss) | 157,843,000.00 | 178,780,000.00 |
Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|
Profit (loss) | N/A | 157,843,000.00 | 178,780,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -279,876,000.00 | -88,960,000.00 |
Cash and cash equivalents | 545,027,000.00 | 268,546,000.00 | 179,654,000.00 |
Please note that some sums might not add up.
IT0004056880
LEIZYXJDNVM2JI3VBM8G556
SectorHealth Care Equipment & Services
IndustryFTSE MIB
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.